• Obatala Sciences

  Led · Series A · Oct 2022

  Obatala Sciences develops patented and patent-pending human-derived hydrogels, adult human stem cells from a diverse biobank, media for cell growth and differentiation, and tissue chip kits (including fat-on-chip and pancreas-on-a-chip under development) for research and drug discovery. The company’s products are sold to pharmaceutical companies, government labs, and academic researchers to provide more predictive, human-based data across diverse populations. Obatala positions its solutions as a response to limitations of 2D cell culture and animal-derived data, aiming to reduce failure rates and time to market for therapeutics. The company was founded in 2017 and is based in New Orleans. Its stated near-term plans include commercialization of pipeline products, building out a lab at The Beach at UNO research park, obtaining ISO certifications, and expanding North American and international distribution. Management also plans to deepen sales, marketing, and customer support teams to support a growing global customer base.

• Socially Determined

  Participated · Series A · Jan 2020

  Socially Determined provides Social Risk Intelligence through its SocialScape® SaaS platform and advisory services, aggregating data and proprietary analytics to reveal where social risk exists and how it affects health outcomes. The platform is designed for payers, life sciences companies, providers and other stakeholders to reduce healthcare disparities and improve engagement. The company has an expanded partnership with CareFirst BlueCross BlueShield to serve CareFirst’s 3.5 million members through an enterprise-wide deployment of SocialScape. Socially Determined said it has gathered data sets on factors like food insecurity, transportation barriers, and financial strain and built analytics and expertise to standardize SDOH assessment at scale. Headquartered in Washington, D.C., it was recently named by Fierce Healthcare as one of the 15 most promising healthcare companies. The company closed a $26 million Series B and will use proceeds to fund product enhancements, sales and marketing, and R&D focused on further technology and platform automation. Socially Determined builds analytics focused on the science and measurement of social determinants of health (SDOH). Its flagship platform, SocialScape®, quantifies social risk and delivers insights into how SDOH affect utilization, cost, and outcomes. The technology is supported by a team of experts who provide SDOH program evaluation, deep cohort analysis, and guidance to clients. The company helps clients grow lines of business into new geographies and risk arrangements through analytic insights. Socially Determined plans to use the Series A proceeds to continue expanding operations and its business reach. The company was co-founded in 2017 by Trenor Williams, MD, Ryan Bosch, MD, and Anthony Beverina and is based in Washington, DC, with a second office in Blacksburg, VA.

• HealthLoop

  Participated · Equity · May 2017

  HealthLoop is a patient engagement and care coordination business based in Mountain View, California. Its platform supports post-hospitalization follow-up and gathers patient-related outcomes after surgery, tracking physical therapy and home care visits. The company says its software improves communication between physicians and patients and has reduced adverse events and surgical complications. HealthLoop serves a mix of middle-market, single-specialty practices and hospitals, counting more than 70 hospitals and medical groups as customers. Financially, the company has completed the first close of an $8.4 million financing round and is expanding sales and marketing/commercial teams with the proceeds. It cites the CMS bundled payment program for joint replacement as a growth driver and sees applications of its platform for chronic conditions such as COPD, congestive heart failure, and diabetes. HealthLoop offers a cloud-based platform that automates how doctors engage with patients after visits, delivering clinical information and peer-reviewed follow-up plans. Its analytics engine parses patient data in real time to surface patients and clinical issues that require attention. The product aims to extend the doctor–patient relationship outside the exam room, reduce unnecessary in-office visits, and improve outcomes while saving doctors time. HealthLoop positions itself as complementary to EHRs and PHRs by focusing on realtime, actionable follow-up and patient monitoring. The company was founded by Dr. Jordan Shlain out of frustration with unreported symptoms between visits. With new funding, HealthLoop plans to ramp hiring, expand development of patient engagement and follow-up tools, and raise awareness among doctors.

• CirraGroup

  Led · Series B · Jul 2016

  CirraGroup offers a cloud-based, crowdsourced medical debt settlement solution that connects patients and providers to resolve unpaid balances in a secure, compliant environment. The company’s suite of applications is designed to increase visibility on unpaid balances and provide avenues for settlement and resolution. CirraGroup positions itself as the first crowdsourced medical debt settlement solution and emphasizes a consumer-focused design. The startup serves hospitals and providers struggling with patient billing complexity and rising out-of-pocket costs. CirraGroup plans to expand and commercialize its solution and continue improving its platform to encourage joint resolution by patients and providers. The company is located in Louisiana and is backed by a strategic investment from the Lafayette General Health Innovation Fund. CirraGroup recently closed a $500,000 Series B equity investment to support these efforts.

No current team members are available.